Journalartikel

BGP SERUM LEVELS IN PATIENTS WITH THYROID-CARCINOMA BEFORE AND 4-14 WEEKS AFTER RADIOIODINE THERAPY


AutorenlisteSTRACKE, H; FEDERLIN, K

Jahr der Veröffentlichung1993

Seiten186-188

ZeitschriftExperimental and clinical endocrinology

Bandnummer101

Heftnummer3

ISSN0232-7384

DOI Linkhttps://doi.org/10.1055/s-0029-1211229

VerlagBarth


Abstract
In the present short paper we compared the BGP and AP levels of 26 patients with thyroid carcinoma during radio-iodine therapy. BGP values reflect the bone turnover before and after radio-iodine therapy. There were no significant AP changes during this period. These results suggest that thyroid hormone has a direct effect on osteoblast function and that this effect can be best monitored by determination of BGP levels.



Zitierstile

Harvard-ZitierstilSTRACKE, H. and FEDERLIN, K. (1993) BGP SERUM LEVELS IN PATIENTS WITH THYROID-CARCINOMA BEFORE AND 4-14 WEEKS AFTER RADIOIODINE THERAPY, Experimental and clinical endocrinology, 101(3), pp. 186-188. https://doi.org/10.1055/s-0029-1211229

APA-ZitierstilSTRACKE, H., & FEDERLIN, K. (1993). BGP SERUM LEVELS IN PATIENTS WITH THYROID-CARCINOMA BEFORE AND 4-14 WEEKS AFTER RADIOIODINE THERAPY. Experimental and clinical endocrinology. 101(3), 186-188. https://doi.org/10.1055/s-0029-1211229



Schlagwörter


BGPBONE GLA-PROTEINhistomorphometryHYPOTHYROIDISMRADIOIODINE THERAPYTHYROID CARCINOMA

Zuletzt aktualisiert 2025-02-04 um 07:49